Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P40 - Multimodality of Advanced Lung Cancer - Clinical Outcomes

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Multimodality of Advanced Lung Cancer
    • +

      P40.08 - Bone-Targeted Agents Improve Survival in High Bone Tumor Burden Advanced Non-Small-Cell-Lung Cancer Patients Treated With PD-(L)1 Inhibitors

      00:00 - 00:00  |  Presenter: Sara Manglaviti

      • Abstract

      Loading...

    • +

      P40.19 - Efficacy and Toxicity of Third-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Sara Manglaviti

      • Abstract

      Loading...

  • +

    P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P45.03 - Tepotinib in Patients with MET exon 14 (METex14) Skipping NSCLC as Identified by Liquid (LBx) or Tissue (TBx) biopsy

      00:00 - 00:00  |  Presenter: Enriqueta Felip

      • Abstract

      Loading...

  • +

    P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P50.06 - First-Line Therapy in NSCLC harbouring EGFR or HER2 Exon 20 Insertion Mutation. Hunting for the Best Candidate

      00:00 - 00:00  |  Presenter: Sara Manglaviti

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.10 - Discussant

      07:48 - 07:55  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.10 - Discussant

      15:48 - 15:55  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

  • +

    WS02 - Early Career Workshop

    • 11:30 - 13:00
    • 9/11/2021
    • Location: Program Auditorium
    • Not for CME Credit
    • Type: Workshop
    • Track: N.A.
  • +

    MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      MA12.03 - A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)

      20:10 - 20:15  |  Presenter: Selina K Wong

      • Abstract

      Loading...

  • +

    IS14 - Industry Symposium Sponsored by Daiichi Sankyo: Targeting NSCLC: Current and Emerging ADC Therapies

    • 16:15 - 17:15
    • 9/13/2021
    • Location: Industry Symposium Auditorium via Industry Hub
    • Not for CME Credit
    • Type: Industry Supported Symposium
    • Track: N.A.
    • +

      IS14.04 - Emerging ADC Targets and Clinical Data in NSCLC

      16:50 - 17:00  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

  • +

    MA16 - SCLC: New Targets, Biomarkers, and Systemic Therapies

    • 20:00 - 21:00
    • 9/13/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer/ NET
    • +

      MA16.06 - Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN

      20:30 - 20:35  |  Presenter: Marina Chiara Garassino

      • Abstract

      Loading...